why take semaglutide on empty stomach Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Semaglutide (Ozempic/Wegovy) has been available

Improves Insulin Sensitivity and Glucose Regulation MOTSc increases the translocation of GLUT4 (glucose transporter) to muscle cells, enhancing glucose uptake without needing insulin spikes

Multiple randomized controlled trials including the SUSTAIN series demonstrate that GLP-1 therapy improves HOMA-IR (a measure of insulin resistance) and fasting insulin levels independent of weight loss alone

This publication is not a healthcare provider, pharmacy, or licensed medical entity, and nothing in this article creates a doctor-patient, pharmacist-patient, or other professional relationship

The Injectable Peptide Fat Loss Landscape in 2025 3